159 related articles for article (PubMed ID: 35142291)
21. Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study.
Alwashmi MF; Fitzpatrick B; Davis E; Farrell J; Gamble JM; Hawboldt J
Ther Adv Respir Dis; 2020; 14():1753466620951044. PubMed ID: 32894025
[TBL] [Abstract][Full Text] [Related]
22. The association between forced expiratory volume in one second (FEV1) and pulse oximetric measurements of arterial oxygen saturation (SpO2) in the patients with COPD: A preliminary study.
Ardestani ME; Abbaszadeh M
J Res Med Sci; 2014 Mar; 19(3):257-61. PubMed ID: 24949035
[TBL] [Abstract][Full Text] [Related]
23. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
Zhang J; Lin XF; Bai CX
Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
[TBL] [Abstract][Full Text] [Related]
25. Is It Possible to Have Home E-Monitoring of Pulmonary Function in Our Patients with Duchenne Muscular Dystrophy in the COVID-19 Pandemic?-A One Center Pilot Study.
Wasilewska E; Sobierajska-Rek A; Małgorzewicz S; Soliński M; Szalewska D; Jassem E
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501557
[TBL] [Abstract][Full Text] [Related]
26. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
[TBL] [Abstract][Full Text] [Related]
27. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
28. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
29. Perceptions of Patients Regarding Mobile Health Interventions for the Management of Chronic Obstructive Pulmonary Disease: Mixed Methods Study.
Alwashmi MF; Fitzpatrick B; Farrell J; Gamble JM; Davis E; Nguyen HV; Farrell G; Hawboldt J
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17409. PubMed ID: 32706697
[TBL] [Abstract][Full Text] [Related]
30. Long-term safety of glycopyrrolate/eFlow
Ferguson GT; Goodin T; Tosiello R; Wheeler A; Kerwin E
Respir Med; 2017 Nov; 132():251-260. PubMed ID: 28919143
[TBL] [Abstract][Full Text] [Related]
31. The utility of hand-held mobile spirometer technology in a resource-constrained setting.
Du Plessis E; Swart F; Maree D; Heydenreich J; Van Heerden J; Esterhuizen TM; Irusen EM; Koegelenberg CFN
S Afr Med J; 2019 Mar; 109(4):219-222. PubMed ID: 31084684
[TBL] [Abstract][Full Text] [Related]
32. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
Mapel DW; Dalal AA; Blanchette CM; Petersen H; Ferguson GT
Int J Chron Obstruct Pulmon Dis; 2011; 6():573-81. PubMed ID: 22135490
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.
Vincken W; Aumann J; Chen H; Henley M; McBryan D; Goyal P
Int J Chron Obstruct Pulmon Dis; 2014; 9():215-28. PubMed ID: 24596459
[TBL] [Abstract][Full Text] [Related]
34. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
35. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Perspectives and Experiences of Older Adults With Asthma and Chronic Obstructive Pulmonary Disease Toward Mobile Health: Qualitative Study.
Kouri A; Gupta S; Straus SE; Sale JEM
J Med Internet Res; 2023 Aug; 25():e45955. PubMed ID: 37606961
[TBL] [Abstract][Full Text] [Related]
37. Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.
Morano JP; Clauson K; Zhou Z; Escobar-Viera CG; Lieb S; Chen IK; Kirk D; Carter WM; Ruppal M; Cook RL
JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12900. PubMed ID: 31271150
[TBL] [Abstract][Full Text] [Related]
38. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
39. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
